Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Single Cell Genomics Markets Forecasts by End User & Technology 2021-2025 with COVID-19 Updates - ResearchAndMarkets.com

December 15, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Dec 15, 2020--

The “Single Cell Genomics Markets Forecasts by End User & Technology. With Executive and Consultant Guides and Including Customized Forecasting and Analysis. With COVID Updates. 2021 to 2025.” report has been added to ResearchAndMarkets.com’s offering.


The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and pitfalls. Understand growth expectations and the ultimate potential market size.

Single Cell Genomics is emerging as a mainstay of scientific research and development. New life forms have already been identified. This means new diseases and new cures.

There are applications in every aspect of healthcare. Just coming out of the lab it is finding its footing in new clinical applications especially related to immune-oncology and microbiology. But the largest market is still in research and the market is booming as understanding the genomics of individual cells opens up a whole new world of biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

Key Topics Covered:

Market Guides

  • Situation Analysis & COVID Update
  • Guide for Executives and Marketing Staff
  • Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

1.1 What is Single Cell Genomics?

1.2 SCG - Still Early Days

1.3 Market Definition

1.4 Methodology

1.5 Sizing the Genome - Not What You Think

1.5.1 Cost, Price and Genome Size, Pricing Practice

1.6 Global Listing of High Throughput Sequencing Establishments Installed Base - Location & Contacts

2. Single Cell Genomics - Guide to Technology

2.1 Isolating Single Cells

2.1.1 FACS

2.1.2 LCM

2.1.3 Micromanipulators

2.1.4 Microfluidics

2.2 Amplification

2.2.1 WTA - Whole Transcriptome Amplification

2.2.2 WGA - Whole Genome Amplification

2.3 PCR

2.4 NGS


2.5 Microarray

2.6 Digital Spatial Profiling (DSP) Technology

3. Industry Overview

3.1 Players in a Dynamic Market

3.1.1 Academic Research Lab

3.1.2 Genomic Instrumentation Supplier

3.1.3 Cell Separation and Viewing Instrumentation Supplier

3.1.4 Cell Line and Reagent Supplier

3.1.5 Pharmaceutical or Reagent Company

3.1.6 Audit Body

3.1.7 Certification Body

4. Market Trends

4.1 Factors Driving Growth

4.1.1 Immuno-oncology

4.1.2 Research Range

4.1.3 Technology Maturity & Convergence

4.1.4 Declining Costs

4.2 Factors Limiting Growth

4.2.1 Competition

4.2.2 Instrument Integration

4.2.3 Technology Shift

4.2.4 Technology Limitations

4.3 Technology Development

4.3.1 Spatial Profiling

4.3.2 Integration

4.3.3 Big Data

4.3.4 Kits and Commodities

5. Single Cell Genomics Recent Developments

5.1 Recent Developments - Importance and How to Use This Section

5.1.1 Importance of These Developments

5.1.2 How to Use This Section

  • DNTR-Seq Combines WGS, Transcriptomics in Single Cells
  • BitBiome Builds Single-Cell Bacterial Sequencing Business
  • S2 Genomics Signs Distribution Agreements for Asia-Pacific
  • Single-Cell COVID-19 Study Investigates Immune Hyperactivation
  • Levitas Bio to Launch Magnetic Levitation Cell Separation Platform
  • Single-Cell and Spatial Genomics
  • Single-Cell Genomics
  • Namocell, Takara Bio, HepaTx Partner on Single-Cell Genomics
  • Vizgen Launches With $14M Series A Financing
  • SeqWell Raises $9M in Series B Round
  • MGI Tech Introduces Portable Sequencer, Single-Cell Prep Device
  • Celsius Therapeutics to Use Single-Cell Platform in Immuno-Oncology
  • Genomics Expects $271M In Proceeds
  • Celsius Therapeutics, Janssen Biotech Form Biomarker Discovery Alliance
  • Bio-Rad, 10x Genomics Claim Single-Cell Patent Fight Victories on Different Fronts
  • Bio-Rad Launches its Single Cell scATAC-Seq Solution
  • Genomics Acquires Spatial Transcriptomics
  • Takara Bio strengthens its IP position on single cell RNA-seq
  • Mission Bio Launches Tapestri for Targeted Single-Cell DNA Custom Panels
  • SingulOmics Detects Somatic Single Nucleotide Variations in Single Cells
  • 1CELLBIO and OMI to validate Single Cell Analysis for Personalized Medicine
  • Sony MA900 Cell Sorter Nominated
  • UNC Cure Center and Cell Microsystems Receive NIH Contract for Single Cell HIV
  • Diagnostic Assay
  • Bio-Rad’s dd-PCR tests for leukemia cleared
  • IncellDx’s Single Cell Immuno-Oncology/PD-L1 Technology used in new Cancer Assay
  • Cytena GmbH land EUR 3M in Series A
  • NanoString Announces Launch of CAR-T Panel
  • Dolomite Bio launches high throughput single nuclei profiling on Nadia platform
  • Silicon Biosystems Develops New Assay for Circulating Multiple Myeloma Cells

6. Profiles of Key Single Cell Genomics Companies

  • Genomics
  • 1CellBio
  • Agilent
  • Beckman Coulter
  • Becton Dickinson
  • Bio-Rad
  • Bitbiome
  • Bruker
  • Cell Microsystems
  • Cellsee Diagnostics
  • CellSorter
  • Cytena
  • CytoTrack
  • Dolomite Bio
  • Fluidigm
  • Fluxion Biosciences
  • Illumina
  • IncellDx
  • Labcyte
  • Leica Microsystems
  • Miltenyi Biotec
  • Mission Bio
  • Oxford Nanopore Technologies
  • NanoString
  • Perkin Elmer
  • Qiagen
  • Readcoor
  • S2 Genomics
  • Silicon Biosystems
  • Singulomics
  • Sony
  • Takara Bio
  • Thermo Fisher
  • Watchmaker Genomics

7. Single Cell Genomics Global Market Size

7.1 Global Market Overview by Country

7.2 Global Market Size by Technology - Overview

7.3 Global Market End User - Overview

8. Global Market by Technology

8.1 PCR Market

8.2 qPCR Market

8.3 NGS Market

8.4 Microarray Market

8.5 Other Technology Market

9. Single Cell Genomics Market by End User

9.1 Research Market

9.2 BioPharma Market

9.3 Clinical Market

9.4 Other End User Market

10. Appendices

10.1 FDA Cancer Drug Approvals by Year

10.2 Clinical Trials Started 2010 to 2016

10.3 Prevalence of Cancer Treatments

For more information about this report visit https://www.researchandmarkets.com/r/fa6gux

View source version on businesswire.com:https://www.businesswire.com/news/home/20201215005532/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 12/15/2020 05:53 AM/DISC: 12/15/2020 05:53 AM